---
title: "Cardlytics | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 34.32 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285607816.md"
datetime: "2026-05-07T20:06:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285607816.md)
  - [en](https://longbridge.com/en/news/285607816.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285607816.md)
---

# Cardlytics | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 34.32 M

Revenue: As of FY2026 Q1, the actual value is USD 34.32 M, missing the estimate of USD 37.1 M.

EPS: As of FY2026 Q1, the actual value is USD -0.08, beating the estimate of USD -0.37.

EBIT: As of FY2026 Q1, the actual value is USD -5.741 M.

Cardlytics, Inc. reported its first quarter 2026 financial results, highlighting a shift from stabilization to execution following the successful divestiture of Bridg on March 24, 2026, and subsequent liquidation of PAR shares to bolster its balance sheet.

#### Q1 2026 Financial Performance (vs. Q1 2025)

-   **Revenue from continuing operations**: $34.3 million, a decrease of 39% compared to $56.4 million.
-   **Revenue from Bridg discontinued operations**: An additional $4.2 million was generated.
-   **Billings from continuing operations**: $58.1 million, a decrease of 37% compared to $92.1 million.
-   **Billings from Bridg discontinued operations**: An additional $4.2 million was generated.
-   **Adjusted Contribution from continuing operations**: $19.7 million, a decrease of 28% compared to $27.3 million.
-   **Adjusted Contribution from Bridg discontinued operations**: An additional $3.6 million was generated.
-   **Gross Profit**: $17.141 million, a decrease of 20% from $21.545 million.
-   **Net Loss**: -$4.5 million, an improvement from -$13.3 million.
-   **Adjusted EBITDA**: $0.2 million, an improvement from -$4.1 million.
-   **Adjusted Net Loss**: -$6.2 million, an improvement from -$10.3 million.
-   **Net cash used by operating activities**: -$5.6 million, an improvement from -$6.7 million.
-   **Free Cash Flow**: -$7.9 million, an improvement from -$10.8 million.
-   **Loss from continuing operations**: -$13.798 million, compared to -$10.318 million.
-   **Income (loss) from discontinued operations**: $9.318 million income, compared to -$2.964 million loss.

#### Key Operational Metrics (Q1 2026 vs. Q1 2025)

-   **Cardlytics monthly qualified users (MQUs)**: 197.0 million, an 8% decrease compared to 214.9 million.
-   **Cardlytics adjusted contribution per user (ACPU)**: $0.10, compared to $0.13.

#### Selected Operating Costs (Q1 2026 vs. Q1 2025)

-   **Partner Share and other third-party costs**: $14.597 million, compared to $29.104 million.
-   **Delivery costs**: $2.581 million, compared to $5.786 million.
-   **Sales and marketing expense**: $6.761 million, compared to $10.382 million.
-   **Research and development expense**: $6.430 million, compared to $10.278 million.
-   **General and administrative expense**: $8.281 million, compared to $12.943 million.

#### Balance Sheet Highlights (March 31, 2026 vs. December 31, 2025)

-   **Cash and cash equivalents**: $35.673 million, down from $48.719 million.
-   **Marketable securities**: $24.130 million, up from $0.
-   **Total assets**: $263.909 million, down from $285.641 million.
-   **Total liabilities**: $267.912 million, down from $292.149 million.
-   **Total stockholders’ deficit**: -$4.003 million, an improvement from -$6.508 million.

#### Outlook / Guidance for Q2 2026

Cardlytics anticipates Billings to be between $61.0 million and $67.0 million, and Revenue between $35.0 million and $40.0 million. Adjusted Contribution is expected to range from $20.0 million to $23.0 million, with Adjusted EBITDA projected between -$2.7 million and $1.3 million.

### Related Stocks

- [CDLX.US](https://longbridge.com/en/quote/CDLX.US.md)

## Related News & Research

- [Cardlytics awards 10,320 restricted stock units to 10 new hires under inducement plan](https://longbridge.com/en/news/294513703.md)
- [Cardlytics names Chris Cheng chief legal officer as Nick Lynton exits](https://longbridge.com/en/news/294207837.md)
- [NextDecade Q2 2026 earnings preview](https://longbridge.com/en/news/294252208.md)
- [2 high-yield dividend stocks worth buying before 2026 ends](https://longbridge.com/en/news/294585401.md)
- [Financiera Independencia releases transcript of 2Q26 earnings call](https://longbridge.com/en/news/294544237.md)